The 2020 release of the WHO Classification of Soft Tissue and Bone Tumors, 5th edition, contains several changes driven by new knowledge in the field. These include reclassification of some entities, refinement of risk classification systems, and the inclusion of novel disease processes, many of which are driven by recurrent gene fusions. The most notable changes are described here.
Citations
Citations to this article as recorded by
Management of a rapidly enlarging supraclavicular mass of unknown aetiology Mateo Cukman, Karla Luzaic, Kristina Krstanovic, Sinisa Stevanovic BMJ Case Reports.2024; 17(2): e255774. CrossRef
Pathogenetic and molecular classifications of soft tissue and bone tumors: A 2024 update Andrei Ionut Patrichi, Simona Gurzu Pathology - Research and Practice.2024; 260: 155406. CrossRef